Literature DB >> 6072779

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

L M Lipman, D E Green, N J Snyder, J C Nelson, D H Solomon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6072779     DOI: 10.1016/0002-9343(67)90175-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  15 in total

Review 1.  Pathogenesis of neonatal Graves' disease.

Authors:  J M McKenzie; M Zakarija
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

Review 2.  Aetiology of hyperthyroidism. II.

Authors:  R Hoffenberg
Journal:  Br Med J       Date:  1974-08-24

3.  Treatment of thyrotoxicosis.

Authors:  R S Swerdloff
Journal:  Calif Med       Date:  1970-08

4.  Experimental studies related to autoimmunity in myasthenia gravis.

Authors:  B M Kaufman; G Rushworth; R Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

5.  Management of endocrine ophthalmopathy.

Authors: 
Journal:  Br Med J       Date:  1968-09-07

6.  Acute endocrine ophthalmopathy in a 12-year-old boy with long-acting thyroid stimulator.

Authors:  K L Macoul; A Dellaporta
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

7.  The value of IgG separation for the detection of LATS in human serum.

Authors:  M Bonnyns; L Vanhaelst
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

8.  Investigation of endocrine exophthalmos.

Authors:  A N Bowden; F C Ross
Journal:  Proc R Soc Med       Date:  1969-01

9.  Thyrotoxicosis developing during cyclophosphamide therapy.

Authors:  I R McDougall; W R Greig; H W Gray; J F Smith
Journal:  Br Med J       Date:  1971-10-30

10.  Medical management of thyroid eye disease.

Authors:  Dawn D Yang; Mithra O Gonzalez; Vikram D Durairaj
Journal:  Saudi J Ophthalmol       Date:  2010-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.